Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Domzalski currently holds 416,208 shares of Menlo Therapeutics Inc. (MNLO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Domzalski has been a net seller of MNLO stock. They have purchased $103.5K and sold $113.9K worth of shares.
David Domzalski's most recent insider trade was on Dec 31, 2025, when they sold 12,684 shares at $0.58 per share.
David Domzalski serves as Executive at Menlo Therapeutics Inc. (MNLO). They have executed 65 insider transactions totaling $217.4K over their tenure at the company.
David Domzalski holds the position of Executive at Menlo Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
David Domzalski has shown a selling trading pattern, with $103.5K in total purchases and $113.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David Domzalski was on Sep 8, 2020, when they purchased $103.5K worth of VYNE shares. This transaction involved 75,000 shares at $1.38 per share.
David Domzalski currently owns 416,208 shares of Menlo Therapeutics Inc. (MNLO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Domzalski's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Domzalski has 65 Form 4 filings on record as an insider at Menlo Therapeutics Inc..
Set alerts for David Domzalski and 40,000+ other insiders.